Clinical trials
Withdrawn Osteoporosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 4 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Columbia University | 3 |
| Centre Hospitalier Universitaire, Amiens | 2 |
| Medical University of Vienna | 2 |
| University of Alabama at Birmingham | 2 |
| University of Pittsburgh | 2 |
| Albert Einstein Healthcare Network | 1 |
| Amorphical Ltd. | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Cedars-Sinai Medical Center | 1 |
| Centre Hospitalier Régional d'Orléans | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteoporosis | 43 |
| Bone Diseases, Metabolic | 5 |
| Fractures, Bone | 4 |
| Osteoporosis, Postmenopausal | 3 |
| Endocrine System Diseases | 2 |
| Hip Fractures | 2 |
| Hypercalcemia | 2 |
| Hyperparathyroidism | 2 |
| Hyperparathyroidism, Primary | 2 |
| Musculoskeletal Diseases | 2 |
Trials
Showing 76 to 43 of 43. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.